Highly-sensitive troponin I is increased in patients with gynecological cancers

Elisa Danese, Montagnana M, Martina Montagnana, Silvia Giudici, Giudici S, Silvia Dei Giudici, Aloe R, Rosalia Aloe, Massimo Franchi, Massimo Piergiuseppe Franchi, Gian Cesare Guidi, Giuseppe Lippi
Clinical biochemistry · 2013 · vol. 46(12) , pp. 1135–1138 · doi:10.1016/j.clinbiochem.2013.04.029 · PMID:23660299 · W2015008052
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-12 ⓘ

This study investigated elevated levels of highly-sensitive troponin I in patients diagnosed with gynecological cancers.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectivesTo investigate troponin I (TnI) in patients with gynecological cancers.MethodsHighly-sensitive (HS) and conventional TnI were measured in 25 patients with untreated ovarian cancer, 25 with endometriosis and 25 with benign masses.ResultsBoth HS and conventional TnI were increase in cancer patients. Values above the cut-off were found in 44% and 16% cancer patients using HS and conventional TnI methods, respectively.ConclusionsCardiac involvement is frequent in patients with gynecological cancers and should be preferably assessed using HS troponin immunoassays.

My notes (saved in your browser only)

MeSH descriptors

Genital Neoplasms, Female Immunoassay Troponin I Adult Female Genital Neoplasms, Female Humans Immunoassay Middle Aged Sensitivity and Specificity Troponin I

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

References (15)

Cited by (1)

Source provenance

europepmc
last seen: 2026-09-27T09:11:36.575535+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:18:59.468224+00:00
License: CC0 · commercial use OK